Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiagabine for adjunctive treatment of partial epilepsy
CTR20131851Phase 3Active
- Sponsor
- Beijing Jingwei Yankang Pharmaceutical Research Institute
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tiagabine in epilepsy, sponsored by Beijing Jingwei Yankang Pharmaceutical Research Institute. Started Apr 2014; status: active.
02
Drugs
tiagabine
03
Conditions
epilepsy
Beyond the preview
Go deeper on CTR20131851.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131851.